SBI Dividend Yield Fund
The scheme seeks to provide investors with opportunities for capital appreciation and/or dividend distribution by investing predominantly in a well-diversified portfolio of equity and equity related instruments of dividend yielding companies.
Growthvine rating: 2/5 — ranked #7 of 10 in category.
Fund basics
| Category | Equity: Dividend Yield |
|---|
| NAV | ₹14.39 (as of 2026-10-23) |
|---|
| AUM | ₹8,059 Cr |
|---|
| Expense ratio | 1.53% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Nidhi Chawla |
|---|
| Exit load | 1% for redemption within 30 days |
|---|
Performance & risk
| Sharpe ratio | 0.29 |
|---|
| Standard deviation | 14.28% |
|---|
| Max drawdown | −18.28% |
|---|
| Alpha | 0.66 |
|---|
| Beta | 0.88 |
|---|
Over 5 years, captured 79.6% of NIFTY Dividend Opportunities 50's upside and 67.7% of its downside.
Market cap allocation
| Large cap | 53.4% |
|---|
| Mid cap | 22.0% |
|---|
| Small cap | 24.6% |
|---|
Concentration
| Top 5 holdings | 20.0% |
|---|
| Top 10 holdings | 32.7% |
|---|
| Total holdings | 58 |
|---|
Top holdings
- ICICI Bank Ltd. — 4.8%
- ACME Solar Holdings Limited — 4.1%
- Larsen & Toubro Limited — 3.9%
- LIFE INSURANCE CORPORATION OF INDIA — 3.8%
- Kotak Mahindra Bank Ltd. — 3.4%
- EMBASSY OFFICE PARKS REIT — 2.7%
- InterGlobe Aviation Limited — 2.6%
- Aurobindo Pharma Ltd. — 2.5%
- Nexus Select Trust — 2.5%
- Vedanta Aluminium Metal Limited — 2.5%
Top sectors
- Pharma & Biotech — 12.8%
- Automobile — 10.1%
- Banking & Financial — 8.2%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −7.9% | Q1 (Top) | #3 of 9 |
| 2025 | 6.0% | Q1 (Top) | #3 of 9 |
| 2024 | 14.5% | Q4 (Bottom) | #8 of 9 |